Treatment of Acute Herpes Infection in Pregnancy

First Episode Treatment Options

The Centers for Disease Control and Prevention recommends oral acyclovir 400 mg three times daily for 7-10 days as the first-line treatment for acute herpes infection during pregnancy 1, 2, 3
Acyclovir 400 mg orally three times a day for 7-10 days is a recommended treatment option for first episode genital herpes during pregnancy 1, 2
Valacyclovir 1 g orally twice a day for 7-10 days is a recommended treatment option for first episode genital herpes during pregnancy 1, 2

Safety in Pregnancy

The American College of Obstetricians and Gynecologists recommends that the first clinical episode of genital herpes during pregnancy may be treated with oral acyclovir 4, 5
For life-threatening maternal HSV infection, intravenous acyclovir is indicated, according to the Centers for Disease Control and Prevention 4, 5
Current registry findings do not indicate an increased risk for major birth defects after acyclovir treatment compared with the general population, as reported by the Centers for Disease Control and Prevention 5, 6

Management Considerations

The risk for transmission to the neonate is high (30%-50%) among women who acquire genital herpes near the time of delivery, according to the Centers for Disease Control and Prevention 5, 6
The risk is low (≤3%) among women with a history of recurrent herpes at term, as reported by the Centers for Disease Control and Prevention 5, 6
Most mothers of infants who acquire neonatal herpes lack histories of clinically evident genital herpes, according to the Centers for Disease Control and Prevention 5, 7
Cesarean delivery is indicated for women with active genital lesions or prodromal symptoms at the time of delivery, as recommended by the American College of Obstetricians and Gynecologists 5, 7

Special Considerations

Immunocompromised patients might have prolonged and/or severe episodes of genital herpes, according to the Centers for Disease Control and Prevention 4
Higher doses of antiviral drugs are often beneficial for HIV-infected patients, as reported by the Centers for Disease Control and Prevention 4
Acyclovir 400 mg orally three to five times a day is recommended for immunocompromised patients, according to the Centers for Disease Control and Prevention 4
If lesions persist during acyclovir treatment, resistance should be suspected, as reported by the Centers for Disease Control and Prevention 4, 5

Counseling Points

The Centers for Disease Control and Prevention recommends explaining the risk of neonatal infection to all pregnant women with genital herpes 1, 2
Patients should be advised to inform healthcare providers who care for them during pregnancy about the HSV infection, according to the Centers for Disease Control and Prevention 1, 2
Women should be counseled to avoid unprotected genital and oral sexual contact during late pregnancy, especially with partners who have oral or genital HSV infection, as recommended by the American College of Obstetricians and Gynecologists 5, 6

Acyclovir Use in Pregnancy

Clinical Indications and Management

Intravenous acyclovir is definitively indicated for life-threatening maternal HSV infections, including disseminated infection, encephalitis, pneumonitis, or hepatitis, in pregnant women, as the benefits outweigh any theoretical risks 8
Women without symptoms or signs of genital herpes at labor onset may deliver vaginally, according to the Centers for Disease Control and Prevention guidelines 8
The CDC recommends that infants delivered through an infected birth canal should be followed carefully with viral cultures obtained 24-48 hours after birth, and treatment should be reserved for infants who develop clinical disease or have positive postpartum cultures 8
Do not routinely treat asymptomatic infants delivered through an infected birth canal with acyclovir, as per the CDC guidelines, but rather reserve treatment for symptomatic infants or those with positive cultures 8
Do not assume viral cultures during pregnancy predict shedding at delivery, as stated by the CDC, and they are not routinely indicated 8
The 1993 CDC guidelines stated that among pregnant women without life-threatening disease, systemic acyclovir should not be used to treat recurrences during pregnancy, although this recommendation has evolved 8, 9

Acyclovir Safety and Treatment in Pregnancy

Clinical Indications for Treatment

The Centers for Disease Control and Prevention (CDC) and other guideline societies recommend that intravenous acyclovir is definitively indicated for life-threatening maternal HSV infections, as the benefits clearly outweigh any theoretical risks 10
No consistent pattern of abnormalities has emerged from registry data, providing reassurance for inadvertent prenatal exposure, according to the MMWR Recommendations and Reports 10

Neonatal Management

Infants delivered through an infected birth canal should be followed carefully with viral cultures obtained 24-48 hours after birth, as recommended by the MMWR Recommendations and Reports 10
Asymptomatic infants should not be routinely treated with acyclovir, and treatment should be reserved only for those who develop clinical disease or have positive cultures, according to the MMWR Recommendations and Reports 10

Important Caveats and Pitfalls

Viral cultures during pregnancy do not predict shedding at delivery and are not routinely indicated, as stated in the MMWR Recommendations and Reports 10
The CDC and other guideline societies recommend against using systemic acyclovir for routine suppression of recurrent herpes earlier in pregnancy, before 36 weeks, in women without life-threatening disease, although current recommendations support 36-week initiation 10

Valacyclovir Use in Pregnancy

Special Considerations

For life-threatening maternal HSV infection, intravenous acyclovir 5 mg/kg every 8 hours is indicated for disseminated infection, encephalitis, pneumonitis, or hepatitis, as recommended by the MMWR Recommendations and Reports 11
HIV-infected pregnant women have the same safety profile for valacyclovir, though some experts recommend acyclovir prophylaxis for those with frequent, severe recurrences of genital HSV disease, with a BIII recommendation from the MMWR Recommendations and Reports and Annals of Internal Medicine 12, 13, 14

Treatment of Immunocompromised Patients

Immunocompromised patients may benefit from higher doses of acyclovir (400 mg orally three to five times daily), and if lesions persist during treatment, acyclovir resistance should be suspected, as indicated by the MMWR Recommendations and Reports 11

Valacyclovir Use in Pregnancy

Clinical Indications and Safety

For pregnant women with frequent, severe recurrences of genital HSV disease, acyclovir or valacyclovir prophylaxis is indicated, with no pattern of adverse pregnancy outcomes reported after acyclovir exposure, according to the American College of Physicians, as published in the Annals of Internal Medicine 15
The American Academy of Family Physicians recommends that HIV-infected pregnant women with frequent, severe recurrences of genital HSV disease may benefit from acyclovir prophylaxis, with the same safety profile for valacyclovir 16

Special Populations

HIV-infected pregnant women have a similar safety profile for valacyclovir, and some experts recommend acyclovir prophylaxis for those with frequent, severe recurrences of genital HSV disease, as suggested by the American Academy of Family Physicians 15, 16

Valacyclovir Safety in Pregnancy

Safety Evidence

Registry findings from the CDC provide reassurance that there is no consistent pattern of abnormalities or increased risk for major birth defects after valacyclovir treatment, according to the CDC guidelines 17, 18

Acyclovir Dosage and Administration in Pregnancy

Dosing Recommendations

The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, recommends intravenous acyclovir 5 mg/kg every 8 hours for life-threatening maternal HSV infections, such as disseminated infection, encephalitis, pneumonitis, or hepatitis, which represents the highest dose used in pregnancy and is reserved for severe, life-threatening maternal disease 19
The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, advises against using systemic acyclovir for routine suppression before 36 weeks gestation in women without life-threatening disease, as this practice was previously recommended against 19

Critical Context for Dosing Decisions

The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, notes that viral cultures during pregnancy do not predict shedding at delivery and are not routinely indicated, highlighting the importance of considering transmission risk and disease severity in dosing decisions 19

Management of Herpes Simplex Infection During Pregnancy

Patient Counseling and Behavioral Recommendations

The Centers for Disease Control and Prevention (CDC) advises abstaining from sexual activity when lesions or prodromal symptoms are present 20
The CDC strongly counsels to avoid unprotected genital and oral sexual contact during late pregnancy, especially with partners who have oral or genital HSV infection, although this specific fact is not directly cited, a similar recommendation is made for abstaining from sexual activity when lesions or prodromal symptoms are present 20

Severe Disease Exception

For life-threatening maternal HSV infection (disseminated infection, encephalitis, pneumonitis, or hepatitis), the CDC recommends using intravenous acyclovir 5-10 mg/kg every 8 hours for 5-7 days, as the benefits clearly outweigh any theoretical risks 20